Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma

• Κύριοι συγγραφείς: Yue Chen (Συγγραφέας), Yutao Wang (Συγγραφέας), Jin Lei (Συγγραφέας), Bowen Chen (Συγγραφέας), Xinfeng Zhang (Συγγραφέας), Liangzheng Chang (Συγγραφέας), Zhangli Hu (Συγγραφέας), Yun Wang (Συγγραφέας), Yinying Lu (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background and aims: Tyrosine kinase inhibitors (TKIs) combined with programmed cell death protein-1 (PD-1) have significantly improved survival in patients with unresectable hepatocellular carcinoma (uHCC), but effective biomarkers to predict treatment efficacy are lacking. Peripheral blood bile ac...